tiRNA-Gly-GCC-1 was discovered to diminish TLR4 expression via directly targeting 3ʹUTR of TLR4 in urothelial bladder carcinoma (Qin et al. 2022). The gene discussed is TLR4; the disease is bladder transitional cell carcinoma.